• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

The Role of Technology in Preventing and Managing Diabetes

Podcast

Given the high cost of treating diabetes and the large population with prediabetes, prevention has become a point of focus. We’re taking a look back to 2017, when The American Journal of Managed Care® convened a panel of experts to discuss diabetes prevention and the use of technology.

Currently, 30 million people in the United States have diabetes and the American Diabetes Association estimates that the total economic cost of disease was $327 billion in 2017. An additional 84 million American adults have prediabetes, and 90% of them don’t know they have it, according to the CDC.

Given the high cost of treating diabetes and the large population with prediabetes, which puts them at an increased risk of developing type 2 diabetes, prevention has become a point of focus. At the annual meeting of the American Association of Diabetes Educators, held August 17 to 20, prevention and delay of type 2 diabetes was one of the 2018 priority topics.

Today, we’re taking a look back to 2017, when The American Journal of Managed Care® convened a panel of experts to discuss diabetes prevention and the use of technology.

To listen, login to the website.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

Peer Exchange—Technology in Diabetes Care: From Prevention to Disease Management

American Association of Diabetes Educators 2018 coverage

CDC—Prediabetes: Your Chance to Prevent Type 2 Diabetes

American Diabetes Association—Statistics About Diabetes

How Technology Can Make CMS' Diabetes Prevention Program Viable

April 1 Brings Day One of the Medicare Diabetes Prevention Program, and Challenges for Health Plans

Read more about the stories in this podcast:

Related Videos
Beau Raymond, MD
Dr Kevin Mallow, PharmD, BCPS, BC-ADM, CDCES
Ian Neeland, MD
Chase D. Hendrickson, MD, MPH
Steven Coca, MD, MS, Icahn School of Medicine, Mount Sinai
Matthew Crowley, MD, MHS, associate professor of medicine, Duke University School of Medicine.
Susan Spratt, MD, senior medical director, Duke Population Health Management Office, associate professor of medicine, division of Endocrinology, Metabolism, and Nutrition,
Stephen Nicholls, MD, Monash University and Victorian Heart Hospital
Amal Agarwal, DO, MBA
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.